Cargando…

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation

BACKGROUND & AIMS: The contribution of abnormal metabolic targets to hepatocellular carcinoma (HCC) progression and the associated regulatory mechanisms are attractive research areas. High-density lipoprotein binding protein (HDLBP) is an important transporter that protects cells from excessive...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jingsheng, Lv, Tao, Yang, Jian, Wu, Zhenru, Yan, Lvnan, Yang, Jiayin, Shi, Yujun, Jiang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772558/
https://www.ncbi.nlm.nih.gov/pubmed/36244648
http://dx.doi.org/10.1016/j.jcmgh.2022.10.005

Ejemplares similares